Pages that link to "Q35951291"
Jump to navigation
Jump to search
The following pages link to Living with or without cyclins and cyclin-dependent kinases (Q35951291):
Displaying 50 items.
- Protein kinase C signaling and cell cycle regulation (Q21131217) (← links)
- Restriction beyond the restriction point: mitogen requirement for G2 passage (Q21203560) (← links)
- Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas (Q24299520) (← links)
- Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling (Q24301328) (← links)
- Functional characterization of human PFTK1 as a cyclin-dependent kinase (Q24306566) (← links)
- HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression (Q24307735) (← links)
- The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation (Q24317091) (← links)
- CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor (Q24321230) (← links)
- CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P (Q24322065) (← links)
- Cyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility (Q24337518) (← links)
- Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells (Q24338283) (← links)
- Functional high-throughput screening identifies the miR-15 microRNA family as cellular restriction factors for Salmonella infection (Q24490032) (← links)
- Negative regulation of nuclear divisions in Caenorhabditis elegans by retinoblastoma and RNA interference-related genes (Q24536288) (← links)
- EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair (Q24608279) (← links)
- Requirement of Cdk4 for v-Ha-ras-Induced Breast Tumorigenesis and Activation of the v-ras-Induced Senescence Program by the R24C Mutation (Q24608910) (← links)
- Cellular senescence and tumor suppressor gene p16 (Q24629853) (← links)
- G2E3 is a dual function ubiquitin ligase required for early embryonic development (Q24649733) (← links)
- Profile of palbociclib in the treatment of metastatic breast cancer (Q26747737) (← links)
- Novel Molecular Markers for Breast Cancer (Q26753160) (← links)
- PP2A: more than a reset switch to activate pRB proteins during the cell cycle and in response to signaling cues (Q26823704) (← links)
- Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors (Q26827580) (← links)
- The cell cycle and pluripotency (Q27009037) (← links)
- The structure of CDK4/cyclin D3 has implications for models of CDK activation (Q27653913) (← links)
- D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells (Q27690967) (← links)
- Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. (Q27851940) (← links)
- The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress (Q28068986) (← links)
- Targeting CDK4 and CDK6: From Discovery to Therapy (Q28082912) (← links)
- Senescence from G2 arrest, revisited (Q28088672) (← links)
- Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia (Q28119158) (← links)
- Cyclin D as a therapeutic target in cancer (Q28242623) (← links)
- Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors" (Q28246814) (← links)
- IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation (Q28267530) (← links)
- Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle (Q28268021) (← links)
- Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo (Q28281137) (← links)
- Cyclins: roles in mitogenic signaling and oncogenic transformation (Q28289852) (← links)
- p65 Negatively regulates transcription of the cyclin E gene (Q28395949) (← links)
- Identification of G1-regulated genes in normally cycling human cells (Q28474350) (← links)
- Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells (Q28482913) (← links)
- Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo (Q28483640) (← links)
- Tight function zonula occludens-3 regulates cyclin D1–dependent cell proliferation (Q28505301) (← links)
- The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration (Q28509576) (← links)
- NFATc1 balances quiescence and proliferation of skin stem cells (Q28511548) (← links)
- Transforming growth factor beta 1 promotes cell cycle exit through the cyclin-dependent kinase inhibitor p21 in the developing cerebral cortex (Q28566256) (← links)
- CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes (Q28568912) (← links)
- NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis (Q28574908) (← links)
- Activation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes (Q28580587) (← links)
- Cdk1 interplays with Oct4 to repress differentiation of embryonic stem cells into trophectoderm (Q28585309) (← links)
- CDK6 as a key regulator of hematopoietic and leukemic stem cell activation (Q28587749) (← links)
- Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells (Q28590731) (← links)
- Control of Caenorhabditis elegans germ-line stem-cell cycling speed meets requirements of design to minimize mutation accumulation (Q28610712) (← links)